Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911061
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-06-19
Brief Title:
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent XBBBA5Delta Protein Vaccine Sf9 Cell in Booster Vaccination
Sponsor:
WestVac Biopharma Co Ltd
Organization:
WestVac Biopharma Co Ltd
Organization Data
Organization:
WestVac Biopharma Co Ltd
Class:
INDUSTRY
Study ID:
WSKCT015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
WestVac Biopharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None